Sulindac - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for sulindac and what is the scope of freedom to operate?
Sulindac
is the generic ingredient in two branded drugs marketed by Merck, Ani Pharms, Chartwell Rx, Epic Pharma, Epic Pharma Llc, Rising, Sun Pharm Industries, and Watson Labs, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.There are fourteen drug master file entries for sulindac. Nine suppliers are listed for this compound.
Summary for sulindac
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 8 |
NDAs: | 12 |
Drug Master File Entries: | 14 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 32 |
Patent Applications: | 6,581 |
Drug Prices: | Drug price trends for sulindac |
Drug Sales Revenues: | Drug sales revenues for sulindac |
What excipients (inactive ingredients) are in sulindac? | sulindac excipients list |
DailyMed Link: | sulindac at DailyMed |
Recent Clinical Trials for sulindac
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Healx Limited | Phase 2 |
Johns Hopkins University | Phase 2 |
Duke University | Phase 2 |
Pharmacology for sulindac
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for sulindac
Anatomical Therapeutic Chemical (ATC) Classes for sulindac
US Patents and Regulatory Information for sulindac
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epic Pharma Llc | SULINDAC | sulindac | TABLET;ORAL | 073262-001 | Sep 6, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Epic Pharma Llc | SULINDAC | sulindac | TABLET;ORAL | 073262-002 | Sep 6, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Rx | SULINDAC | sulindac | TABLET;ORAL | 072713-001 | Aug 30, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for sulindac
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | CLINORIL | sulindac | TABLET;ORAL | 017911-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Merck | CLINORIL | sulindac | TABLET;ORAL | 017911-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Merck | CLINORIL | sulindac | TABLET;ORAL | 017911-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.